Pharmabiz

WHO and partners launch new strategy to build a healthier market for childhood cancer medicines

WHO and partners launch new strategy to build a healthier market for childhood cancer medicines: Geneva Thursday, September 17, 2026, 14:00 Hrs [IST] On the occasion of childhood ...
Pharmabiz

Dr. Reddy Labs expands collaboration with Gilead Sciences through voluntary licensing agreement for investigational once-yearly lenacapavir for HIV prevention

Dr. Reddy Labs expands collaboration with Gilead Sciences through voluntary licensing agreement for investigational once-yearly lenacapavir for HIV prevention: Our Bureau, Mumbai ...
Pharmabiz

Eli Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026

Eli Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026: Indianapolis Thursday, September 17, 2026, 13:00 Hrs [IST] Eli Lilly and Company the maker of Ze ...
Pharmabiz

Union health ministry to mandate CCTV surveillance at medical stores to strengthen regulatory oversight

Union health ministry to mandate CCTV surveillance at medical stores to strengthen regulatory oversight: Our Bureau, New Delhi Thursday, September 17, 2026, 12:15 Hrs [IST] The Un ...
Pharmabiz

Ono Pharma receives manufacturing & marketing approval in Japan for Xcopri tablets to treat patients with partial-onset seizures, with or without secondary generalized seizures

Ono Pharma receives manufacturing & marketing approval in Japan for Xcopri tablets to treat patients with partial-onset seizures, with or without secondary generalized seizures: O ...
Pharmabiz

Stem cell therapy to be permitted as standard care only for approved list of diseases; Union health ministry

Stem cell therapy to be permitted as standard care only for approved list of diseases; Union health ministry: Our Bureau, New Delhi Thursday, September 17, 2026, 11:15 Hrs [IST] T ...
Pharmabiz

Chugai obtains Japanese approval for FoundationOne CDx Cancer Genomic Profile as a companion diagnostic of tovorafenib for BRAF V600 alterations and BRAF fusion gene-positive ...

Chugai obtains Japanese approval for FoundationOne CDx Cancer Genomic Profile as a companion diagnostic of tovorafenib for BRAF V600 alterations and BRAF fusion gene-positive glio ...
Pharmabiz

First Canadian commercial use of Abbott’s Volt Pulsed Field Ablation System advances minimally invasive atrial fibrillation care

First Canadian commercial use of Abbott’s Volt Pulsed Field Ablation System advances minimally invasive atrial fibrillation care: Mississauga, Ontario Thursday, September 17, 20 ...
Pharmabiz

Enhertu & Datroway approved in Japan for two new first-line indications for patients with metastatic breast cancer

Enhertu & Datroway approved in Japan for two new first-line indications for patients with metastatic breast cancer: Tokyo Thursday, September 17, 2026, 09:00 Hrs [IST] Enhertu (tr ...
Pharmabiz

IISc & DTU develop nanobody based anti-venom for broad protection against deadly cobra toxins

IISc & DTU develop nanobody based anti-venom for broad protection against deadly cobra toxins: Nandita Vijayasimha, Bengaluru Thursday, September 17, 2026, 08:00 Hrs [IST] Indian ...
Pharmabiz

NABL to introduce upfront payment system for NABL accreditation towards ease of doing business

NABL to introduce upfront payment system for NABL accreditation towards ease of doing business: Shardul Nautiyal, Mumbai Thursday, September 17, 2026, 08:00 Hrs [IST] As part of N ...
Pharmabiz

Karnataka FSDA embarks on probe into drug racket scam along with SIT: Minister

Karnataka FSDA embarks on probe into drug racket scam along with SIT: Minister: Nandita Vijayasimha, Bengaluru Thursday, September 17, 2026, 08:00 Hrs [IST] Karnataka Food Safety ...